Supporting evidence

High-intensity interval exercise × HbA1c

Authoritative support
5
Available studies
5
Unavailable support
0

Available supporting studies

Study 1 · Included

HIIT and Aerobic-Resistance Training Improve Diabetes Outcomes

Rct

Comparison
Participants engaged in a 12 week intervention that included an individualised combined aerobic and resistance exercise training program along with standard hospital care. · Participants underwent a HIIT program adapted for safety and physical capacity, involving structured interval sessions. · The control group received standard hospital care without a structured exercise program.
Duration / follow-up
12 weeks

Relevant effects

Mean difference

3.33

Mean difference

3.35

View research →

Study 2 · Included

HIIT Improves Glucose Control in Diabetic Neuropathy Patients

Rct

Comparison
Participants engaged in a 12 week high intensity interval training program. · Participants engaged in a 12 week moderate intensity continuous training program. · Participants maintained their usual daily activities and received health education.
Duration / follow-up
24 weeks

Relevant effects

Mean difference

1.11 · 0.001

Mean difference

0.81 · 0.001

View research →

Study 3 · Included

HIIT improves glycaemic control and pancreatic function in T2D patients

Rct

Comparison
T2D patients undergoing HIIT to assess effects on glycaemic control and pancreatic function. · Healthy individuals matched for age, height, and weight to T2D patients.
Duration / follow-up
35 weeks

Relevant effect

Mean difference

0.5 · 0.04

View research →

Study 4 · Limited

Interval walking training may improve physical fitness in type 2 diabetes

Comparison
Participants performed interval walking training for 20 weeks.
Duration / follow-up
20 weeks
View research →

Study 5 · Included

Low-volume HIIT improves glycaemic control in type 2 diabetes

Rct

Comparison
Participants engaged in 8 weeks of supervised c hiit training. · Participants engaged in 8 weeks of supervised c mict training. · Participants continued with usual care for 8 weeks before being re randomised.
Duration / follow-up
52 weeks

Relevant effects

Mean difference

0.7 · 0.014

Mean difference

1.2 · 0.001

View research →